Global DNA hypomethylation in CD4+ cells in systemic lupus erythematosus (sLe) was suggested to play a key role in the pathogenesis. to identify new methylation-sensitive genes, we integrated genome-wide DNA methylation and mRNA profiling data in CD4+ cells of MRL/lpr (MRL) and C57BL6/J (B6) mice. We identified Cathepsin E (Ctse), in which 13 methyl-CpGs within 583 bp region of intron 1 were hypomethylated, and Ctse mRNA upregulated in MRL compared with B6 mice. One of methyl-CpGs, mCGCG was 93.3 ± 2.05% methylated in B6 mice, while 80.0 ± 6.2% methylated and mutated to CGGG in MRL mice. Kaiso is known to bind to mCGCG and we hypothesized that it represses expression of Ctse in B6 mice. The binding of Kaiso to mCGCG site in B6 mice was reduced in MRL mice revealed by ChIP-PCR. EL4 cells treated with 5-azaC and/or Trichostatin A showed the suppression of binding of Kaiso to mCGCG motif by ChIp-pCR and the overexpression of Ctse was demonstrated by qpCR. Ctse gene silencing by siRNA in EL4 cells resulted in reduction of IL-10 secretion. The hypomethylation of mCGCG motif, reduced recruitment of Kaiso, and increased expression of Ctse and Il-10 in CD4+ cells may be involved in the pathogenesis of sLe.
Scientific RepoRts | (2019) 9:3054 | https://doi.org/10.1038/s41598-019-38809-y miRNA and mRNA profiling in CD4+ T cells purified from spleen of MRL/lpr lupus-prone mice (MRL) and compared with the C57BL/6 (B6) and isolated miR-200a-3p, which is involved in the hypoproduction of IL-2 in T cells by targeting CtBP2 complex 10 . To identify the putative methylation-sensitive genes involved in the pathogenesis of SLE, we performed the integration analysis of genome-wide DNA methylation and global mRNA profiling in CD4+ T cells purified from spleen of MRL and compared with B6 mice. During the screening, we have identified cathepsin E (Ctse) gene, in which 13 methyl-CpG-dinucleotides located within 583 bp region of intron 1 were hypomethylated, and Ctse mRNA was highly expressed in MRL mice compared with B6 mice. One of 13 methyl-CpGs, methyl-CGCG (mCGCG) in B6 mice was hypomethylated as well as mutated to CGGG in MRL mice. Kaiso (ZBTB33; zinc finger and BTB domain) is a member of to the BTB (BR-C, ttk, and bab)/ POZ (Pox virus and zinc finger) family, and reported to bind to DNA with dual-specificity in both a sequence-(Kaiso-binding site; CTGCNA) and methyl-CpG (mCGCG) specific manner via C2H2 zinc finger (ZF) 11 and methyl-DNA-binding (MBD) domains 12 , respectively.
Here, we demonstrate that Kaiso directly binds to mCGCG site in intron 1 of Ctse gene in methyl-CpG-dependent manner and represses the transcriptional activity of Ctse in B6 mice, while the demethylation and mutation of mCGCG to CGGG caused the reduced binding of Kaiso and up-regulated expression of Ctse. In immune-mediated cells, Ctse was shown to be involved in processing of antigenic peptides during MHC class II-mediated antigen presentation in dendritic cells and macrophages 13 . In contrast, the role of Ctse in T cells in normal physiology and pathobiology in autoimmune diseases remains unexplored. We also found that knockdown of Ctse gene in cultured EL4 cells resulted in decreased production of IL-10 and that up-regulated expression of IL-10 was observed in CD4+ T cells isolated from MRL mice compared with B6 mice. IL-10 is known to be elevated in the serum and tissues of patients with systemic lupus erythematosus (SLE) and the expression of IL-10 is activated by Stat3 (signal transducer and activator of transcription 3) in peripheral CD4+ T cells 14 .
Because of its B cell-promoting effects, T cell-derived IL-10 may contribute to autoantibody production and tissue damage in SLE. In this communication, we postulate that Ctse represents a new methylation-sensitive gene, like previously recognized CD70, CD40L and CD11a 15 , contributes to the pathogenesis of SLE.
Results
Ctse gene is hypomethylated and upregulated in CD4+ t cells of MRL mice. To identify novel methylation-sensitive genes in SLE, we integrated genome-wide DNA methylation and mRNA profiling data in splenic CD4+ T cells isolated from MRL and compared with B6 mice. The differentially expressed 188 genes with statistical significance revealed by Cuffdiff program were merged with 1,557 enriched regions with significant methylation peaks demonstrated by MACS program. The 7 genes were identified and they were associated with significant methylation peaks in B6 mice but not in MRL mice ( Supplementary Table 1 ). Since RNA sequence data demonstrated most abundant and highly up-regulated expression and of Ctse in splenic CD4+ T cells from MRL mice, we next investigated the expression of Ctse in immune-mediated cells. The mRNA and protein levels of Ctse prominently were increased in splenic CD4+ T cells from MRL compared with those from B6 ( Fig. 1A,B , and Supplementary Fig. 1 ). Although Ctse was shown to be involved in processing of antigenic peptides during MHC class II-mediated antigen presentation in macrophages, the expression was prominently up-regulated in CD4+ and CD8+ T cells, and B cells in MRL mice, but it is not the case with macrophages ( Fig. 1A,B ).
In genome-wide DNA methylation analysis, the methylated region expanded 583 bp in intron 1 of Ctse in B6 mice was identified by MACS program, while it was hypomethylated in MRL mice ( Supplementary Table 1 and Fig. 1C ). Two peaks observed in MRL mice were excluded as duplicate reads by MACS program (Fig. 1C ). Next, we searched the specific methylated CpGs by bisulphite sequencing in this region. From B6 (n = 1) and MRL (n = 1) mice, genomic DNAs were isolated, bisulphite converted, 440 bp region including 13 CpGs in intron 1 of Ctse amplified by PCR, cloned, and sequenced. As shown in Fig. 1D , 2 CpGs were mutated, while 11 CpGs were hypomethylated in MRL compared with B6. We searched candidate transcription factors which bind to the 583 bp methylated region in intron 1 through JASPAR database. Kaiso was found and it is known to specifically recognize the methylated DNA motif (mCGCG) through the C2H2 zinc-finger domains, recruits the SMRT (Silencing Mediator of Retinoic acid and Thyroid hormone receptors)/N-CoR (Nuclear hormone receptor Co-Repressor)/HDAC3 (Histone deacetylase 3) complex, leading to suppression of its target gene 16 (Fig. 1E ). Indeed, mCGCG motif at 11 th CpG site ( Fig. 1D , boxed) demonstrated to be mutated to CGGG and 21.7% reduction of DNA methylation in MRL (76.9%) compared to B6 mice (98.6%). Furthermore, bisulphite converted genomic DNAs from B6 (n = 5) and MRL (n = 5) were sequenced to confirm the difference of DNA methylation pattern between B6 and MRL. The 11 th CpG was hypomethyalted in MRL (80.0 ± 6.2%) compared with B6 (93.3 ± 2.05%) (p = 3.82 × 10 −5 ) ( Fig. 1D ). the binding of Kaiso to mCGCG was reduced by hypomethylation. To determine the impacts of hypomethylation of mCGCG motif on the transcriptional regulation of Ctse, we induced DNA hypomethylation in EL4 cells using well-known DNA methylation inhibitor, 5-azaC. The genomic DNA was purified from EL4 cells treated with or without 1 μM of 5-azaC for 48 hours and incubated with the methylation-sensitive restriction enzyme AccII, which digests only unmethylated CGCG motifs. By the treatment of 5-azaC, the intensity of PCR products derived from AccII-resistant mCGCG was reduced, while those from AccII-sensitive unmethylated CGCG unaltered ( Fig. 2A, Supplementary Fig. 1 ). Next, EL4 cells were treated with 5-azaC and/or histone deacetylase (HDAC) inhibitor, Trichostatin A (TSA). The levels of Ctse mRNA expression were up-regulated under the treatment of 5-azaC or TSA in EL4 cells and we also observed the additive effects under simultaneous treatment of 5-azaC and TSA (Fig. 2B ). Since TSA inhibits HDACs 1, 3, 4, 6, and 10, and it is not specific only for HDAC3, we next performed ChIP-qPCR to check the binding of Kaiso and HDAC3 to CGCG motif in EL4 cells. Under the treatment of 5-azaC and TSA in EL4 cells, ChIP-qPCR demonstrated that the bindings of Kaiso and HDAC3 to the hypomethylated CGCG motif seemed to be reduced without statistical differences ( Fig. 2C Supplementary Fig. 1 ). Since the treatment of EL4 cells with 5-azaC results in global hypomethylation, we cannot negate the possibility that the increase in Ctse expression is caused by hypomethylation of other regions of genomic DNA. Thus, we next compared AccII-resistant mCGCG and AccII-sensitive unmethylated CGCG in CD4+ T cells derived from B6 and MRL mice. The ratio of AccII-resistant mCGCG was reduced in MRL mice ( Fig. 2A ). In addition, the bindings of Kaiso and HDAC3 to the Ctse intron 1 in CD4+ T cells of MRL and B6 mice. ChIP-qPCR revealed that Kaiso and HDAC3 bindings to the Ctse intron 1 were reduced in MRL CD4+ T cells compared with B6 CD4+ T cells ( Fig. 2D , Supplementary Fig. 1 ).
Binding of Kaiso to Kaiso regulatory region of Ctse gene. To demonstrate the binding of Kaiso to
Kaiso regulatory region of Ctse gene, we incubated nuclear proteins from EL-4 cells with labeled double-stranded oligonucleotides containing the CGCG motif (Supplementary Table 2 ). In EMSA (Fig. 3A) , the biotin-labeled methylated wild type probe (B6-Me; mCGCG) formed DNA-protein complex (asterisk), which were supershifted 
Kaiso regulates the Ctse promoter activity. To demonstrate transcriptional repression activity of
Kaiso, we subcloned the Kaiso regulatory region with CGCG motif and PU.1 promoter region with PU.1 binding site into pGL4.10 [luc2] Vector. PU.1 promoter region was known to display the most potent promoter activity of Ctse 17 . The various constructs are shown in Fig. 4A and Supplementary Fig. 2 . pGL4.10-MRL/MRL construct demonstrated the highest luciferase activity, while pGL4.10-B6/B6 construct revealed significantly lower luciferase activity ( Fig. 4B ). It suggested that CGCG motif at Kaiso regulatory region is critical for the repression of transcriptional activity of Ctse gene. We next investigated the effect of DNA methylation of Kaiso regulatory region. The methylation of constructs significantly and prominently repressed luciferase activities in pGL4.10-MRL-Me/MRL-Me and pGL4.10-B6-Me/B6-Me constructs compared with corresponding unmethylated constructs (Fig. 5B ). Taken together, Kaiso bind to the mCGCG motif in Kaiso regulatory region and repress its transcriptional activity.
Ctse knockdown in EL4 cells reduces IL-10 secretion in EL4 cells. The treatment of EL4 cells by
si-CTSE resulted in the 60% reduction of mRNA expression of Ctse compared with si-Control (negative control) treated cells ( Fig. 5A ). Although the reduction of Ctse did not significantly alter the mRNA expression of Il10 after the stimulation with PMA/Iono (Fig. 5B ), the secretion of IL-10 into the culture media was significantly reduced at 24 hours after the stimulation with PMA/Iono ( Fig. 5C ), suggesting suppressed secretion of IL-10 was not caused by the reduction of transcriptional activity of Il10. The viability of EL4 was investigated by Trypan Blue and the percentage of live cells are similar in both si-Control and si-CTSE groups (Fig. 5C ). The upregulation of Ctse in CD4+ T cells in MRL mice was associated with the upregulation of transcriptional activity of Il10 (Fig. 5D ). The upregulated expression of Il10 under the control of Ctse was specific phenomenon by the treatment of si-CTSE and it was down-regulated in CD4+ T cells from MRL mice ( Fig. 5B,D) . The tumor suppressor, programed cell death 4 (Pdcd4), inhibits the translation of Il10 transcripts and the secretion is enhanced in splenocytes in Pdcd4 knockout mice 18 . As shown in Fig. 5D , mRNA expression of Pdcd4 in CD4+ T cells was higher in B6 mice compared to MRL mice, as previously reported 19 . Taken together, the hypomethylation and mutation of a Kaiso-binding site in the Ctse intron 1 prevents the biding of Kaiso-HDAC3 complex, which may link to the Supplementary Fig. 3 ).
CTSE and IL10 mRNA were elevated in CD4+ t cells from the patients with sLe. We investigated the expression levels of CTSE and IL10 mRNAs in circulating CD4+ T cells isolated from SLE patients and healthy subjects. The demographics of enrolled SLE patients are shown in Supplementary Table 3 . SLE patients also showed the similar tendency with MRL mice; the expression level of Ctse and IL10 mRNAs in CD4+ T cells is upregulated in lupus patients than healthy control (Fig. 6A,B) , while PDCD4 mRNA lower tendency in lupus patients than healthy control (Fig. 6C ). However, there was no significant correlation between Ctse and IL10 mRNA expression levels (Fig. 6D ). Although we searched the correlation with clinical parameters appeared in Supplementary Table 3 , we failed to demonstrate the correlation of Ctse and IL10 mRNA expression levels with any clinical parameters.
Discussion
Methylation of target sequences prevents the binding of certain transcriptional activators, such as AP-2, thereby suppressing gene expression 20 . Methyl-CpG-binding proteins (MBPs) are able to prevent the binding of transcription factors and suppress gene expression from a distance 21 , and it also attracts chromatin remodeling complexes that modify adjacent histones, resulting in a condensed nucleosome structure, making the locus inaccessible to transcription factors 22 . Methylated DNA can be recognized by MBPs, which belong to three different structural families in mammals: the MBD family, Kaiso-like proteins, and the SRA (SET and RING finger associated domain) proteins 23 . They are involved in many biological and pathological processes, including control of genome stability, early embryonic development, neuron maturation, and T cell differentiation, as well as human diseases such as Rett syndrome and cancer 24 . The transcription factors which regulate the expression of Ctse had been reported. Cook et al. reported that the expression of the Ctse gene is probably dependent upon the balance between positive-acting, tissue-specific transcription factors such as GATA1 and PU1, and the negative influence of the ubiquitous factor YY1 25 . Okamoto et al. identified the several unique transcriptional activators, such as Sp1, AP-1 and cEts-1 for the mouse Ctse gene 17 . In current investigation, we present the first evidence that Ctse as a newly identified methylation-sensitive gene, which is involved in the pathogenesis of SLE. Specifically, CD4+ T cells from MRL mice demonstrated decreased binding of the transcriptional factor Kaiso to Kaiso regulatory motif at intron 1 of Ctse gene because of its lower methylation status and point mutation. Importantly, upregulated Ctse expression level in T cells correlated with the IL-10 expression in EL4 cells and CD4+ cells from MRL mice. The upregulation of IL-10 in lupus T cells is well-known 14 and Pdcd4, the know suppressor of IL-10 production 26 , is reported to be down-regulated in lupus T cells 19 . In EL4 cells and CD4+ cells from MRL mice, increased production of IL-10 and reduced expression of Pdcd4 were observed. Although the precise molecular mechanism remains unknown, the knockdown of Ctse gene resulted in reduced IL-10 release. Among various cathepsins, it has been reported that the inhibition of cathepsin S (Ctss) may suppress disease activity of SLE and lupus nephritis 27 . The deficiency of Blimp-1, transcriptional repressor of Ctss, in dendritic cells (DCs) led to increased Ctss expression, which resulted in a more diverse repertoire of follicular helper T cell (Tfh cell) contributing to autoimmunity in female C57BL/6 mice. A treatment of Blimp-1 knockout mice with Ctss inhibitor abolished the lupus-related phenotype and reduced the diversity of the Tfh cell TCR repertoire 28 . The elevated expression of Blimp-1 was induced by IL-12 in a STAT4-dependent manner and IL-10 expression in Th1 cell was up-regulated by Blimp-1 29 . The elevated Blimp-1 in SLE patients and in MRL mice positively correlated with the increase in plasma cells, autoantibodies and disease activity 30 as suppressive mechanisms by inducing apoptosis, promoting programmed regulated necrosis (necroptosis), and inhibiting cell proliferation 33 to compensate for loss of IL-10 and IL-35 33 . Treg cells from Il10 (−/−) mice, which fetal loss induced by LPS was at high frequency, were increased in pregnancy and the expression of Ctse, Ifng, and Il12rb2 in Treg cells was also enhanced 34 . 293 T cells which were transfected with expression plasmids encoding TRAIL limited T cell proliferation, and was further enhanced in the presence of expression plasmids encoding Ctse 33 . This suggests that Ctse may play a role in enhancing the function of TRAIL by either increasing its activity via processing or increasing the generation of soluble TRAIL 35 . Expression of IL-10 and/or IL-35 by wild-type Tregs may suppress Ctse expression and thus reduce the contribution of TRAIL-mediated killing. Chloroquine, an anti-malarial drug, which has immune-modulating activity and lysosomotropic activity, enhanced TRAIL mediated apoptosis in cancer cells 36 . SLE patients had significantly greater expression of TRAIL, TNF-like weak inducer of apoptosis (TWEAK), and FasL on CD4+ T cells than healthy control, which correlated with disease activity 37 . It has been reported that increased T cell Ctse and subsequent TRAIL expression may exacerbate lupus by increasing CD4+ Th cell numbers and inhibiting CD8+ Tcytotoxic T cell-mediated killing of autoreactive B cells 38 and it may not be a compensatory mechanism to limit lupus activities. In contrast to MRL mice, Tulone, C., et al. reported the natural Ctse deficiency in immune system of B6 mice because of a polymorphism of the promotor region of Ctse damped promotor activity of PU.1 binding consensus sequence in B6 mice. The deficiency is cell-type-specific, as protein levels in gut are not affected, while the deficiency affects B cell, T cells, macrophages and dendritic cells 39 . The reduction of Ctse expression is largely dependent on the genetic background of B6 mice rather than Fas lpr mutation. The role of IL-10 whether it promotes or limits disease activity of SLE remains controversial. Autoimmune lymphoproliferative syndrome (ALPS) is an inherited disorder in which genetic defects in proteins that mediate lymphocyte apoptosis, most often Fas, are associated with enlargement of lymph nodes and the spleen and a variety of autoimmune manifestations like MRL mice. ALPS patients have dramatic elevations in circulating IL-10, and double negative T cells (DNTC) are the dominant producers of IL-10 when assessed ex vivo 40 . Although immunosuppressive therapy of ALPS patients decreases DNTC and serum IL-10 levels 41 , the roles of DNTC and IL-10 remain unclear. IL-10/Janus kinase/signal transducer and activator of transcription 3 (STAT3) pathway drives the expression of Bim, anti-apoptotic Bcl-2 family member, in DNTC derived from ALPS patients 42 . The severity of lupus in MRL mice were enhanced by the deletion of Il10 gene. It was associated with enhanced IFN-γ production by both CD4+ and CD8+ Tcells and increased serum concentration of IgG2a anti-dsDNA autoantibodies 43 . Administration of rIL-10 reduced IgG2a anti-dsDNA autoantibody production and Th1 cytokine responses in wild-type MRL-Fas(lpr) in early phase 43 . Although the beneficial role of IL-10 has been reported, anti-IL-10 antibody may have a beneficial effect at later phases of disease, because excessive amounts of IL-10 production may lead to enhanced autoantibody production and subsequent formation of pathogenic autoantibody-Ag complexes 44 . In addition to IL-10-dependent mechanisms, Ctse plays another key role for the development of SLE. Ctse deficiency caused autophagy impairment concomitantly with increased damaged mitochondria as well as increased oxidative stress 45 . Aberrant autophagy played an important role in the development of SLE 46 . Gros et al. detected more autophagosomes in mice and human lupus T lymphocytes 47 . Chen, J., et al. found that increased autophagy in T cells from SLE patients due to energy "starvation", excessively accumulated mitochondria and over-activated autophagy promoted apoptosis of T cells from SLE patients 48 . Since the accumulated defective mitochondria could not match the high energy consumption within T cells in lupus with high disease activity, they may thus induce apoptosis, subsequently increasing autoantibody formation 49 . Thus, the regulation of energy state of T cells could probably be a new treatment target for SLE. Chloroquine, which blocks lysosomal degradation, prevented the contents in autolysosome from recycling and was unable to maintain cellular energy levels. Ctse works for lysosomal degradation and relate to mitochondrial function such as intracellular ATP levels, mitochondrial membrane potential, and mitochondrial oxygen consumption 45 . Based on line of evidences, one can suppose that overexpression of Ctse may be compensatory mechanism acting to limit lupus severity, Ctse will suppress the increased autophagy via elevation of defective mitochondria in lupus.
In conclusion, we presented the evidence that hypomethylation and mutation of the mCGCG site of the Ctse intron 1 in MRL mice disrupt the ample binding of Kaiso which results in increased expression of Ctse and Il10 in SLE T cells. Whether upregulation of Ctse and Il10 is compensation or promoting factors for disease activity of SLE remains for future investigation.
Methods
Mice. Genetically lupus-prone female MRL/MpJ-Fas lpr /J (MRL) mice, B6.MRL-Fas lpr /J mice (B6MRL) (Jackson Laboratory), and C57BL/6 J (B6) mice (Charles River Laboratories) were purchased. At 16 weeks of age, MRL and B6 mice were sacrificed, and their spleen tissues were collected.
Isolation of mouse primary T cells, B cells and peritoneal macrophages. Mouse splenic CD4+
T cells, CD8+ T cells, B cells were isolated using a CD4 isolation kit II (Miltenyi Biotec), CD8a isolation kit II (Miltenyi Biotec) and PanBcell isolation kit II (Miltenyi Biotec) by negative selection, respectively. A purity rate of >96.6% for isolated CD4+ T cells, CD8+ T cells and B cells were confirmed by flow cytometry. Peritoneal macrophages were obtained from B6 and MRL mice by washing their peritoneal cavities with 15 ml of ice-cold saline. The cells from individual mice were centrifuged at 1500 rpm for 5 minutes at 4 °C, washed in complete DMEM (Life Technologies) supplemented with 10% FBS (Life Technologies), 100 U/ml penicillin, and 100 μg/ml streptomycin, and subsequently adjusted to 1 × 10 7 cells/ml. The cells were cultured on 12-well flat-bottom tissue culture plates (Corning) and incubated for 3 hours at 37 °C under 5% CO 2 air.
Genome wide DNA methylation and mRNA profiling using a next-generation sequencer.
Genomic DNAs and total RNAs were purified from CD4+ T cells of MRL mice and B6 mice using All Prep DNA/ RNA Mini Kit (Qiagen). The quality of the DNA was confirmed by fluorometer using Qubit dsDNA BR Assay Kits (Invitrogen). EpiXplore Methylated DNA Enrichment Kit (Clontech) was used for enriching methylated DNA fragments from the genomic DNA. First, we prewashed TALON Magnetic Beads and couple MBD2 protein to magnetic beads, bound methylated DNA to MBD2 protein/magnetic beads complexes, removed non-and hypomethylated DNA, eluted, and purified the methylated DNA. Illumina TruSeq ChIP Sample Prep Kit was used for the construction of sequencing libraries, and they were subjected to sequencing using Illumina HiSeq. The previously published mRNA sequencing data 10 appeared in Gene Expression Omnibus (https://www.ncbi. nlm.nih.gov/geo/) under the accession number GSE87219 was analyzed with Cuffdiff program, and integrated with genome wide DNA methylation profiling data (GSE102421). In brief, significant methylation peaks in B6 and MRL mice were identified with model-based analysis of ChIP-Seq (MACS 1.4.2) using parameters bandwidth = 300, mfold = 10,30, and gzise = 1870000000 50 , mapped to genome, differentially methylated regions (DRMs) between B6 and MRL mice identified, and duplicate reads removed. The list of genes with read numbers of mRNA were merged with annotation of enriched regions. The read depth, enriched regions, mapping information was visualized by UCSC Genome Browser.
EL4 cell line culture. The EL4 mouse T cell line was obtained from the American Type Culture Collection and cultured in DMEM (Life Technologies) supplemented with 10% FBS (Life Technologies), 100 U/ml penicillin, and 100 μg/ml streptomycin. A total of 4 × 10 6 cells/ml (EL4 cells or MRL-and B6 mice-derived CD4+ T cells) were treated with 1.0 μM 5-azacytidine (5-azaC; Sigma-Aldrich) for 48 hours and with 30 nM Trichostatin A (TSA; WAKO) at 37 °C in a 5% CO 2 incubator. The concentrations of 5-azaC and TSA were determined by the titration by counting Trypan Blue-negative viable cells. The percentages of viable cells were as follows; 5-azaC (93.3% at 0 μM, 89.6% at 0.2 μM, 82.9% at 1.0 μM, 0% at 5.0 and 10 μM) and TSA (97.5% at 0 nM, 85.4% at 30 nM, 49.6% at 300 nM, 44.6% at 1 μM, 38% at 3 μM).
Bisulphite sequencing. Genomic Sequencing kit (Thermo Fisher Scientific) and methylation patterns at the level of individual CpG sites were examined. Furthermore, the purified PCR products from CD4+ T cells of MRL (n = 1) and B6 (n = 1) mice were individually cloned into a T-vector pD20 using the DNA Ligation Kit Mighty Mix, and transformed to E.coli HST08 Premium Competent Cells (TaKaRa). The 72 plasmid clones in B6 and 65 in MRL were isolated and sequenced.
Methylation specific pCR. To evaluate the methylation status of the CGCG motif in the Ctse promoter, genomic DNA (1 μg) from EL4 cells was purified and treated with EcoRI (TaKaRa) and the methylation-sensitive restriction enzyme AccII (New England Biolabs). mCGCG is resistant to AccII digestion, while CGCG is sensitive. After DNA re-purification, 50 ng of DNA was used as a template, and Primer F2: 5′-ACGGCTTTTGTGTTTTGGCT-3′ and Primer R2: 5′-ACATCAGCACTTAGGTTCTGCT-3′, or Primer R3: 5′-GCCCTGGTTCAATCCCTAAT-3′ were used for PCR. PCR products were electrophoresed on 2% agarose gels, visualized by ethidium bromide staining, and quantified with ImageQuant TL software (GE Health Life Sciences). The PCR products amplified with F2 and R2 corresponds to the amount of AccII-resistant DNA, while the products by F2 and R3 reflects total amount of genomic DNAs.
Patients and T lymphocyte purification. The 15 SLE patients (10 females and 5 males) who fulfilled at least 4 of the 11 revised criteria of the American College of Rheumatology for the classification of SLE 51 enrolled and newly developed the disease. The samples were obtained in prior to the treatments with immunosuppressive agents and glucocorticoids. The disease activity was assessed by the SLE disease activity index (SLEDAI) 52 . The healthy volunteers were recruited as controls. The current clinical investigation was conducted in accordance with the ethical standards laid down in the Helsinki Declaration by the World Medical Association, as well as "Ethical Guidelines for Medical and Health Research Involving Human Subjects" presented by the Ministry of Health, Labour and Welfare. The studies were approved by the Ethical Committee, Okayama University Hospital (#1779). Written informed consents were obtained from all participants. CD4+ T lymphocytes were purified using the RosetteSep Human CD4+ TCD4+ T Cell Enrichment Cocktail (Stem Cell Technologies). The samples were centrifuged over a buoyant density medium, RosetteSep DM-L. The purified CD4+ TCD4+ T cells were recovered from the interface between the plasma and the buoyant density medium. Using flow cytometry, we established that the purified cells were >94% positive for CD4. Subsequently, both RNA and DNA were extracted from CD4+ T cells using the AllPrep DNA/RNA Mini Kit (Qiagen) according to the manufacturer's protocol.
RNA isolation and real-time Rt-pCR.
Total cellular RNAs from human and mouse samples were extracted with an RNeasy mini kit (Qiagen). cDNAs were reverse transcribed from mRNAs with a high-capacity cDNA RT kit (Thermo Fisher Scientific). Real-time PCRs for Ctse (Mm00456010_m1), Il10 (Mm01288386_ m1), Il17a (Mm00439618_m1), Pdcd4 (Mm01266062_m1), Gapdh (Mm99999915_g1) for mouse, CTSE (Hs00157213_m1), IL10 (Hs00961622_m1), PDCD4 (Hs00377253_m1) and GAPDH (Hs02786624_g1) for human were performed using ABI TaqMan gene expression assays (Applied Biosystems) and normalized to GAPDH by the ΔΔCt method ( Supplementary Table 4 ).
Western blot analysis. The lysates of murine splenic CD4+ T cells were prepared by homogenization with
CelLytic M, supplemented with a protease inhibitor cocktail (Sigma-Aldrich). Protein concentration was determined using the Pierce BCA protein Assay kit (Thermo Fisher Scientific). The samples were run on a 4-20% Mini-PROTEIN TGX Precast Gel (Bio-Rad) electrophoresis (SDS-PAGE) and blotted on Amersham Hybond P 0.45 µm PVDF (GE Healthcare Life Sciences). Primary antibodies against CTSE at 1:2,000 dilution (NB400-152, NOVUS) and beta-Actin at 1:1,000 dilution (ab8227; abcam) in 5% bovine serum albumin in TBS supplemented with 0.1% Tween 20 (TBS-T) were incubated overnight at 4 °C. Then, the blots were washed with TBS-T and incubated with donkey anti-rabbit IgG-HRP (1:5,000; SANTA CRUZ) for 45 minutes at room temperature. After three-time washes with TBS-T, bands were visualized with enhanced chemiluminescence using the Pirece Western Blotting Substrate Plus (Thermo Fisher Scientific). Protein bands were semiquantified by densitometry using ImageQuant TL software (GE Healthcare Life Sciences).
Chromatin immunoprecipitation (ChIp)-qpCR. ChIP-qPCR was performed in accordance with the manufacturer's instructions (Cell Signaling Technology). Briefly, cells were cross-linked with 1% formaldehyde. After the cross-linked cells were lysed, the chromatin was harvested and fragmented with enzymatic digestion using micrococcal nuclease. Nuclear extracts were further treated with an ultrasound sonicator with three sets of 20-s pulses. Immunoprecipitations were performed with Kaiso (ab12723; Abcam) and HDAC3 (ab7030; Abcam) antibodies. After DNA-protein cross-links were reversed, the DNA was purified, and qPCR was performed with Custom Taqman ™ Gene Expression Assays (AIQJDG8) by forward primer: 5′-GCCTTCGGTGTGCATGCTA-3′ and reverse primer 5′-CACTTAGGTTCTGCTTATGGTAACGT-3, and probe 5′-TTTCCCCGCGAGACTT-3′ and all values were standardized with input DNA.
eLIsA. The amount of IL-10 protein secreted in the supernatants from cell cultures was measured by ELISA in accordance with the manufacturers' instructions (mouse IL-10 ELISA Ready-SET-Go!, eBioscience). The absorbance was determined using a microplate reader set at 450 nm.
small Interfering RNAs (siRNAs) transfections. EL4 cells were transfected with 5 μM si-CTSE (Ctse Silencer Select Pre designed siRNA ID: s64606 and s64607) or si-Negative-Control (Si-Control) using Neon electroporation system (Thermo Fisher Scientific) in serum-free medium with one pulse with a voltage of 1080 Volts and width of 50 ms. Twenty-four hours after transfection, 10 6 cells/ml were stimulated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 1 μM Ionomycin (Sigma-Aldrich).
Cell transfection. The transfection of plasmids into EL4 cells was performed using Neon electroporation system (Thermo Fisher Scientific) in serum-free medium with one pulse with a voltage of 1080 Volts and width of 50 ms. pGL4.10 [luc2] derived constructs ( Supplementary Fig. 2 ). Following the transfection, 2 × 10 5 EL4 cells were cultured in 24-well plates and harvested after 24-hour incubation. Cytoplasmic extracts were prepared using a luciferase assay kit (Promega) in accordance with the manufacturer's instructions. statistical analyses. All results are shown as the mean ± standard deviation (SD) of data from at least three separate experiments, each performed with more than triplicate samples. The differences between the groups were analyzed using ANOVA with a Tukey-Kramer post hoc test or an unpaired t test, when appropriate, to determine the differences. P values less than 0.05 were considered significant. All statistical analyses were performed using the JMP 11.2.0 software package (SAS Institute). ethical approval and informed consent. The experiments were approved by the Animal Care and Use
